HOME >> BIOLOGY >> NEWS
U.S. commission makes dramatic recommendations for ocean health

SEATTLE, WA In June 2003, the Pew Oceans Commission released recommendations "to avert decline of ocean wildlife and collapse of ocean ecosystems." It calls for immediate reform of U.S. ocean laws and policies to restore ocean wildlife, protect ocean ecosystems, and preserve the ecological, economic and social benefits the oceans provide in essence, a 'Clean Oceans Act.'

In the next few weeks, the U.S. government will issue a draft report giving its recommendations for ocean policy. The new policy will address a broad range of issues, from the stewardship of marine resources and pollution prevention to enhancing and supporting marine science, commerce and transportation.

At the 2004 AAAS Annual Meeting, leaders from both the Pew and U.S. Commissions will appear for the first time together to discuss the findings of their respective reports.

"The current situation emphasizes exploitation. It is short-term focused, myopic and has, in fact, resulted in degradation in ocean environment. Sustainable ecosystems will sustain long-term exploitation," said renowned marine scientist, Jane Lubchenco of Oregon State University.

The presentation today at the 2004 AAAS (Triple-A-S) Annual Meeting will stress the need for new ocean regulations by Ecosystem-Based Management. Andrew Rosenberg from the University of New Hampshire and a member of the U.S. Commission on Ocean Policy are expected to describe ecosystem-based management as multi-sector, multi-species and across physical boundaries of the land/sea interface.

"This means trying to manage coherently the different parts of the ecosystem so you don't only manage the target species, but look at the cumulative impact. For example, you think hard about how you can fit together the management of fisheries at the same time you're trying to protect turtles," Rosenberg explained.

As Chairman of the Pew Oceans Commission, Leon Panetta will summarize the findings of the commission'
'"/>

Contact: Monica Amarelo
mamarelo@aaas.org
206- 774-6330
American Association for the Advancement of Science
14-Feb-2004


Page: 1 2

Related biology news :

1. National ocean commissioners & scientists call for overhaul of ocean policies & management
2. Review article makes case for a new source of cells in the body
3. Virus known for its photo ops makes its movie screen debut
4. Study: A little help from friends makes wounds heal faster
5. Purdue yeast makes ethanol from agricultural waste more effectively
6. Scientists learn how adjuvant makes vaccines effective
7. Mutant biological machine makes proteins but cant let go
8. Research bank makes good use of umbilical cords
9. Genetic trick adapted from viruses makes gene therapy vectors more versatile
10. Scientists seek cause for what makes good cell go bad
11. The biological clock: What really makes us tick

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: commission makes dramatic recommendations for ocean health

(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... advanced fluid applications and designed for continuous operation up to 1500 bar. The ... ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is ...
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
(Date:7/29/2015)... FRANCISCO , July 29, 2015  AsureQuality ... mobile molecular testing for applications in food and ... hand-held, battery powered real-time PCR device, the Freedom4. ... farm right through to the supermarket shelf for ... This includes involvement in animal disease control and ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
Cached News: